Moreover, we identified oncogenic β-catenin–boosted de novo pyrimidine synthesis via stimulation of the AKT2–CAD (carbamoyl-phosphate synthetase 2, aspartate transcarbamoylase, dihydroorotase) signaling pathway in liver cancer development and its clinical significance in cancer treatment. This evidence concerns the gene AKT2 and liver cancer.